-
3-Hydroxybutyrate (BHBA) in Neuroprotection
2026-09-10
3-Hydroxybutyrate (BHBA) is more than a ketone fuel: it is a metabolic signal, membrane-active metabolite, and class I HDAC inhibitor with potential relevance to ferroptosis and neuroprotection. This translational guide interprets stroke findings, defines validation workflows, positions BHBA against competing experimental strategies, and outlines how to use it as a mechanistically resolved research tool without overstating clinical evidence.
-
Intraarticular RTX for Osteoarthritic Pain
2026-09-09
The 2025 review evaluates intraarticular resiniferatoxin (RTX) as a high-potency TRPV1-directed intervention for osteoarthritic pain, integrating cellular, animal, canine, and early human evidence. Its central innovation is the use of localized TRPV1 activation to produce chemical inactivation of pain-sensing terminals, while highlighting dose, volume, administration route, and evidence maturity as critical translational variables.
-
EZ Cap™ EGFP mRNA: Practical Workflow
2026-09-09
EZ Cap™ EGFP mRNA provides a Cap 1 EGFP reporter mRNA input for testing delivery and expression in research systems. It is appropriate for controlled reporter assays, but the supplied information does not define a universal dose, cell type, delivery reagent, readout window, or expected performance outcome.
-
Annexin V-Cy5 Apoptosis Kit: A Better Readout
2026-09-08
The Annexin V-Cy5 Apoptosis Kit provides a rapid phosphatidylserine-based apoptosis assay for separating cell death from reversible lysosomal dysfunction. This guide develops an interpretation-first workflow for zebrafish microglia, combining flow cytometry apoptosis detection with fluorescence microscopy apoptosis analysis.
-
Remdesivir (GS-5734): Mechanism and Evidence
2026-09-08
Remdesivir, also called GS-5734, is a monophosphoramidate prodrug that delivers a nucleoside analogue to viral RNA-dependent RNA polymerase. Cellular and animal data support its use as a research tool in coronavirus antiviral research and Ebola virus treatment research, while polymerase-structure evidence alone does not establish activity against Nipah virus.
-
L-Ornithine Workflows for Urea Cycle Research
2026-09-07
L-Ornithine supports controlled studies of OTC activity, ammonia disposal, and liver–brain metabolic signaling. This workflow-focused guide shows how to prepare the reagent, build metabolic enzyme assays, connect hepatic findings with astrocyte models, and troubleshoot solubility or interpretation problems.
-
HyperScript First-Strand cDNA Synthesis Kit for qPCR
2026-09-07
Turn difficult RNA inputs into actionable cDNA for PCR amplification and qPCR, including low-abundance bacterial transcripts and structured targets. This workflow shows how to select primers, tune reverse transcription, and reproduce the GlmS–sigB expression logic reported in Staphylococcus aureus biofilm research.
-
RepSox in iPSC Platelet Differentiation
2026-09-05
RepSox is a potent ALK5 inhibitor with a distinctive role in induced pluripotent stem cell reprogramming and TGF-β pathway research. This evidence-aware guide explains how to evaluate RepSox as a mechanistic variable in iPSC-derived platelet workflows without confusing validated findings with testable hypotheses.
-
Localized BDNF Release in Early NMJ Formation
2026-09-04
This study identifies muscle-cell podosome-like structures as spatial platforms that capture and release BDNF during the earliest stages of neuromuscular junction development. Using live imaging, targeted perturbations, and muscle-specific knockout mice, the authors show that activity-dependent BDNF trafficking and furin-mediated processing regulate aneural and subsequent synaptic acetylcholine receptor clustering.
-
Bufuralol Hydrochloride in β-Adrenergic Research
2026-09-04
Bufuralol hydrochloride is a non-selective β-adrenergic receptor antagonist with partial intrinsic sympathomimetic activity. Its documented cardiovascular pharmacology profile supports receptor-blockade, exercise-response, and tachycardia animal model studies, while hiPSC-derived intestinal organoids provide a separate human-relevant platform for absorption and metabolism research.
-
MnTBAP Chloride: Mitochondrial Stress Workflows
2026-09-03
MnTBAP Chloride provides a practical SOD-mimetic intervention for separating mitochondrial superoxide effects from downstream inflammation, energy failure, and cell injury. This workflow translates evidence from paraquat, inflammatory, and chronic-stress models into controlled assays with clearer dosing, sampling, and troubleshooting decisions.
-
S1PR3 Drives Neuronal Apoptosis After ICH
2026-09-03
The reference study identifies an S1P–S1PR3 mechanism that links acute intracerebral hemorrhage to TNF-α elevation, PI3K/AKT-associated signaling, and caspase-3-dependent neuronal apoptosis. Using mouse and HT22-cell models, the authors show that pharmacological S1PR3 inhibition reduces apoptotic markers and improves neurological outcomes, positioning S1PR3 as a candidate target for secondary brain injury research.
-
Aconitase Activity Assay in T-Cell Metabolism
2026-09-02
The Aconitase Activity Colorimetric Assay Kit provides a functional view of TCA-cycle integrity that complements studies of CD28–ARS2–PKM metabolic flexibility. This guide explains assay interpretation, oxidative damage measurement, controls, and translational limits.
-
Bufuralol hydrochloride in Organoid PK Studies
2026-09-02
Bufuralol hydrochloride combines broad β-adrenoceptor blockade with partial intrinsic sympathomimetic activity, making it useful for exposure, transport, and cardiovascular pharmacology workflows. This guide translates hiPSC-derived intestinal organoid findings into practical dosing, sampling, comparison, and troubleshooting strategies.
-
GDC-0941: A Mechanism-First Assay Guide
2026-09-01
GDC-0941 is a selective PI3K inhibitor for dissecting PI3K/Akt signaling, proliferation, and therapy resistance. This mechanism-first guide connects assay design with findings from pancreatic cancer research to improve interpretation beyond routine pathway inhibition workflows.